After 21 Years and a Spinoff, Profitability Finally Arrives
Ironwood Pharmaceuticals is in the black for the first time thanks to its complex spinoff of pre-commercial drug development programs.
Biotech Firms Need a Plan B for Hiring CFOs
There are so many companies in the biotech sector now, their chances of finding a finance chief with the preferred profile are low.
GE Stock Surges on News of Biopharma Sale
The $21 billion sale to Danaher is a "pivotal milestone" in GE's plan to reduce debt and strengthen its balance sheet, CEO Larry Culp says.
Silicon Valley Bank Buys Leerink for $280M
The acquisition will enable to SVB to expand its investment banking services for life sciences companies.
Interim CFO Firm Succeeds by Keeping Sights Narrow
Veteran life-sciences CFOs leverage their specialized expertise to run their own outsourced finance services business.
Bayer Names Outsider Wolfgang Nickl as CFO
The German company is turning to an executive with U.S. corporate experience as it moves forward with its acquisition of Monsanto.
Thermo Fisher Makes Electron Microscopy Move
The lab equipment firm's $4.2 billion purchase of FEI gives it access to technology used by biopharma companies to develop drugs.
Biotech Investor Accused of Stealing $18M
A controller and chief legal officer also played 'integral roles' in the scheme, says the SEC.